CLINICAL_TRIALS
ClinicalTrials.gov record update
A PHASE I DOSE ESCALATION STUDY OF HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY WITH BEVACIZUMAB IN THE TREATMENT OF RECURRENT MALIGNANT GLIOMA
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01392209
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:30.623254+00:00
- Published At
- 2019-11-22T00:00:00+00:00
- Record Updated At
- 2019-11-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Brain Cancer", "MALIGNANT GLIOMA", "Glioblastoma", "Anaplastic Astrocytoma (AA)", "Anaplastic Oligodendroglioma (AO)", "Anaplastic Oligo-astrocytoma (AOA)", "Anaplastic Mixed Gliomas", "Malignant Glioma NOS"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-11-22"- protocolSection.identificationModule.nctId
"NCT01392209"- protocolSection.identificationModule.officialTitle
"A PHASE I DOSE ESCALATION STUDY OF HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY WITH BEVACIZUMAB IN THE TREATMENT OF RECURRENT MALIGNANT GLIOMA"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.